Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT03214562 · RECRUITING
Trial details
- NCT number
- NCT03214562
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-26
- Primary completion
- 2027-09-30
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.